Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

COVID-19 doesn't make alopecia areata worse.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.